About ViiV Healthcare. München, Bayern, Deutschland . US FDA Approval For Juluca® HIV Medication | ViiV ... Visit this section Back Careers . ViiV Healthcare shall in no event be liable to you or to anyone for any decision made or action taken by you based on this information. ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Pneumonia, skin and soft tissue infections. Target Audience This site is intended for US Healthcare Professionals Only. RELEASE DATE: November 24, 2020. By clicking "Allow," you will be taken to a website that is independent of ViiV Healthcare. The conference and this Best of ACTHIV web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., Theratechnologies, and ViiV Healthcare. ViiV Healthcare | GSK GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales. ViiV Healthcare and Halozyme enter global collaboration ... ViiV Healthcare is committed to investigating new treatment options that may help to address some of these challenges with the aim of providing healthcare professionals with alternative treatment . Please refer to your nationally approved label or summary of product characteristics for up-to-date product . Trademarks are owned by or licensed to the ViiV Healthcare group of companies. Shionogi joined in October 2012. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. MRVWCNT210004 October 2021 Produced in USA. These supporters were not involved in the development of content or selection of faculty for this educational activity. Trademarks are owned by or licensed to the ViiV Healthcare group of companies. GlaxoSmithKline stock is approaching a 52-week high after a company it owns a majority stake in received US Food and Drug Administration (FDA) approval for a preventative human immunodeficiency-1(HIV) medicine called Apretude.. ViiV Healthcare announced Tuesday that the FDA approved Apretude, its long-lasting injectable pre-exposure prophylaxis option for use in adults and adolescents weighing . ©2021 ViiV Healthcare or licensor. . Our consumer healthcare products ViiV Healthcare Careers Close menu Careers GSK is a place where talented people do amazing things. "This is a truly critical milestone for HIV pre-exposure prophylaxis providing a safe and effective alternative to daily pills," said Dr. Myron Cohen, HPTN co-principal investigator, and director of the Institute for Global Health at the University of North Carolina . January 2021 The makers of these brands are not affiliated with and do not endorse the ViiV Healthcare group of companies or its products. Trademarks are owned by or licensed to the ViiV Healthcare group of companies. This activity is intended for infectious disease/HIV specialists and primary care physicians. Bristol-Myers Squibb received from ViiV Healthcare a payment of $350 million in connection with the closing. Trademarks are owned by or licensed to the ViiV Healthcare group of companies. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by . A leading global company focused on advancing science into HIV treatment, prevention and care, ViiV Healthcare has had significant recent successes with regulatory approvals and industry leading launches of new antiretrovirals. It also wants to know what interim steps the drugmaker is taking to "protect patients," such as notifying customers and recalling products. Produced in USA. The FDA also approved Vocabria (cabotegravir) which is an oral tablet formulation of Cabenuva. This educational activity is supported by an independent educational grant from ViiV Healthcare. You can find the complete list of our prescription medicines, vaccines and consumer healthcare products available in Belgium on the website of the Belgian Centre for Pharmacotherapeutic Information.. This site is intended for US Healthcare Professionals Only. The goal of this activity is for clinicians to interpret new data presented at recent scientific conferences to prevent HIV infection and optimize treatment strategies for people living with HIV. Where you are encouraged to be you and create a meaningful impact. ie low yearly raises, low bonus, and other expense when traveling for the company. She received her medical degree at University of California San Francisco and completed her training in internal medicine and infectious disease . 3 GSK ESG Performance Summary 2020 March 2021 Data summary continued 2018 2019 2020 Total Notes Access and affordability (continued) Product reach target (800 million by 2025, against a 2018 baseline) Trademarks are owned by or licensed to the ViiV Healthcare group of companies. Target Audience and Goal Statement. 3 Calculated across GSK and ViiV Healthcare products. Trademarks are owned by or licensed to the ViiV Healthcare group of companies. We are ViiV Healthcare Canada. 21-08-2020. ViiV Healthcare, a company exclusively devoted to the HIV/AIDS marketplace, has announced the FDA has approved its latest new injectable therapy combination Cabenuva (cabotegravir and rilpivirine). Impact of COVID-19 on HIV diagnosis and treatment. Our consumer healthcare products ViiV Healthcare Careers Close menu Careers GSK is a place where talented people do amazing things. Registered Office Level 3, 436 Johnston Street, Abbotsford, VIC 3067, ACN 138 687 448 | For product information regarding ViiV Healthcare products or to report an adverse event, please contact GSK Medical . She is the Director of the Madison HIV/Hepatitis Coinfection Clinic at Harborview Medical Center in Seattle, WA. Shionogi joined in October 2012. Careers Close menu . ©2021 ViiV Healthcare group of companies or its licensor. The Food and Drug Administration has, for the first time, approved a long-acting, injectable medicine to protect against HIV in adults and adolescents considered at risk of contracting the virus. It may include information about products or uses that have not been approved by the US Food and Drug Administration. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Produced in USA. ViiV Healthcare supports PhRMA's voluntary Direct-to-Consumer (DTC) principles, which include providing pricing information for all of our products featured in television advertising. This site is intended for US residents only. January 2021 Target Audience and Goal Statement. ViiV Healthcare considers the need for compassionate use for all our investigational medicines early in the planning of our research programs. The site you linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site. Produced in USA. Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content. This website is funded and developed by ViiV Healthcare. Our consumer healthcare products ViiV Healthcare Stiefel dermatology Our consumer healthcare products When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again. This website is funded and developed by ViiV Healthcare. Recommendations based on these needs/ considerations are approved by our Chief Medical Officer. For press contacts at our Global Headquarters or in our local operating companies, please visit our country websites. ©2021 ViiV Healthcare or licensor. Working Student Marketing New Products ViiV Healthcare Mai 2021 -Heute 7 Monate. Antiretroviral (ARV) Agents Market size is expected to reach $36.49 billion by 2027 from $30.89 billion in 2021, registering at a CAGR of 3.8% from 2021 to 2027. Activity Description About ViiV Healthcare. Zyvox®/Zyvoxid® Pharmacia/Pfizer. Shop confident with unbeatable customer service & 100% money back guarantee on all orders. Details GlaxoSmithKline 27 October 2021 ViiV Healthcare announced the release of Achieving health equity: a roadmap to eliminating disparities, a new report conducted by Economist Impact, a division of The Economist Group, that explores the opportunities that could be created by eliminating health disparities in the UK and US over the next 20 years, while charting a bold course for unified action. MRVWCNT210004 October 2021 Produced in USA. Partnering with communities in Canada affected by HIV/AIDS. New Viiv Healthcare jobs added daily. Trademarks are owned or licensed to the ViiV Healthcare group of companies. David A. Wohl, MD. Study product was provided by ViiV Healthcare and Gilead Sciences, Inc. Three other NIH institutes also collaborated on HPTN 083 and HPTN 084: the National Institute of Mental Health, the National . The goal of this activity is to review key data presented in 2021 on management of HIV. Our consumer healthcare products ViiV Healthcare Careers Close menu Careers GSK is a place where talented people do amazing things. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Pneumonia, skin and soft tissue infections. Careers Close menu . Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has completed the previously announced sale of its HIV R&D portfolio to ViiV Healthcare, which includes a number of programs at different stages of discovery, preclinical and clinical development. A company devoted to HIV/AIDS research and treatment and to supporting people affected by HIV/AIDS across Canada. ViiV Healthcare and Shionogi intend to initiate first time in human studies with S-365598 by 2023. Media Contacts for inquiries outside of the US. 600mg FC Tablets. It may include information about products or uses that have not been approved by the US Food and Drug Administration. According to a spokesperson for the drug's manufacturer, ViiV Healthcare, Apretude will be sent to distributors early next year, as reported by the Washington Post.Doctors are hopeful that having . Developed by ViiV Healthcare, Apretude is initially given as two shots one month apart, and then every two months thereafter. Where you are encouraged to be you and create a meaningful impact. GSK - Identifying and Reporting Human Safety Information For GSK and ViiV Healthcare Products Quia - GSK - Identifying and Reporting HSI for GSK ViiV Home FAQ About Log in Subscribe now 30-day free trial The conference and this Best of ACTHIV web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., Theratechnologies, and ViiV Healthcare. Where you are encouraged to be you and create a meaningful impact. Professor of Medicine Institute of Global Health and Infectious Diseases Leverage your professional network, and get hired. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. ©2021 ViiV Healthcare or licensor. Find the best home health and online medical supplies here. Only 19% of Canadians surveyed realise that there are parts of Canada where the rates of infection are higher than Africa. In North America, you can report a side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET. Our HIV business is managed through ViiV Healthcare, a global specialist HIV company established in 2009, that we majority own, with Pfizer and Shionogi as shareholders. Apretude was approved for use in adults and adolescents weighing at least 35 kg who are at risk of sexually acquiring HIV and who have a negative HIV-1 test prior to initiation. EXPIRATION DATE: November 23, 2021. Today's top 240 Viiv Healthcare jobs in United States. The ASAs that are included in this ASA Locator are responsible . Visit this section Back Careers . With over 20 years of pharma experience and 16 years in the HIV therapeutic area, Dacia brings a wide range of skills and expertise to her role. Apretude (cabotegravir), made by ViiV Healthcare, was approved for use in at-risk adults and adolescents weighing at least 77 pounds, to reduce their risk of HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver But with a key patent loss coming in 2028, the company is now placing its bets . We support compassionate use for patient populations meeting specific criteria managed under formal . In 2012 Shionogi joined the company. This website is funded and developed by ViiV Healthcare. This activity is intended for cardiologists, ID/HIV specialists, primary care physicians, nurses, pharmacists, and all clinicians interested in managing lipids in patients living with HIV. Faculty. Buy durable independent living aids & bathroom safety equipment for caregivers and seniors + wide range of braces & supports, physical therapy and foot care products. Linezolid injection. The goal of this activity is to review key data presented in 2021 on management of HIV. ViiV is doing very well as a company but unfortunately because the parent company GSK is not as successful much of the employee perks and benefits have been cut. ViiV Healthcare Pricing Information. ViiV Healthcare ViiV Healthcare is an independent, global specialist HIV company dedicated to delivering innovative new options for the care and treatment of people living with HIV/AIDS. This educational activity is supported by independent educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare. Rising Prevalence of HIV/AIDS to Surge the Market Growth Such an increase in the number of product launches in the HIV drugs category will enhance the market growth. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for . The makers of these brands are not affiliated with and do not endorse the ViiV Healthcare group of companies or its products. The goal of this activity is to improve low-density lipoprotein cholesterol (LDL-C) lowering in persons living with HIV. ©2021 ViiV Healthcare group of companies or its licensor. It may include information about products or uses that have not been approved by the US Food and Drug Administration. On Thursday, ViiV Healthcare, which is majority-owned by GlaxoSmithKline, announced positive 24-week…. Products We make a wide range of prescription medicines, vaccines and consumer healthcare products. Dacia was appointed to the role of General Manager for ViiV Healthcare Canada in November 2019. About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in . ©2021 ViiV Healthcare or licensor. This website is funded and developed by ViiV Healthcare. In Australia, ViiV Healthcare has been involved in supporting research through investigator initiated and pivotal clinical studies, and is actively involved in expanding local access to treatment through compassionate supply. Our consumer healthcare products ViiV Healthcare Careers Close menu Careers GSK is a place where talented people do amazing things. Important Safety Information for Cabenuva (cabotegravir 200 mg/mL; rilpivirine 300 mg/mL . ViiV Healthcare is a global leader focused on advancements in the research and the development of medicines for people living with HIV. ViiV Healthcare (/ v iː v / VEEV) is a pharmaceutical company specializing in the development of therapies for HIV infection that was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company. ViiV Healthcare Investigator-Sponsored Research (ISR) Programme ViiV Healthcare (VH) is an independent, global specialist HIV company established in 2009 with the commitment to deliver innovative new options for the care and treatment of people living with HIV/AIDS. In addition to respiratory and HIV, we have a portfolio of other innovative pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives. München, Bayern, Deutschland Intern Marketing New Products ViiV Healthcare Nov. 2020 - Apr. About ViiV Healthcare. This site is intended for US Healthcare Professionals Only. ViiV Healthcare ViiV Healthcare is an independent, global specialist HIV company dedicated to delivering innovative new options for the care and treatment of people living with HIV/AIDS. When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again. This activity is intended for infectious disease and HIV specialists and primary care physicians. This site is intended for US healthcare professionals only. In November 2017, ViiV Healthcare received the U.S. FDA approval for Juluca in the U.S. Juluca is a single-dose antiretroviral (ART) regimen that suppresses the viral infection. Visit this section Back Careers . Lot's of new changes at ViiV Healthcare some good and some not so good. ViiV Healthcare has a number of other antiretroviral medicines in clinical development. DLLWCNT210018 July 2021 Produced in USA. This site is intended for US residents only. GlaxoSmithKline's dolutegravir has been a staple of its portfolio of HIV drugs under joint venture ViiV Healthcare. Shionogi joined in October 2012. January 2021 Shionogi joined in October 2012. Where you are encouraged to be you and create a meaningful impact. Dr. Nina Kim is an Associate Professor of Medicine and Adjunct Associate Professor of Global Health at the University of Washington (UW). ViiV Healthcare will market CAB-LA for PrEP under the brand name Apretude. Pneumonia, skin and soft tissue infections. About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Upon completion of this activity, participants will: Have increased knowledge regarding the. The conference and this Best of ACTHIV web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., Theratechnologies, and ViiV Healthcare. GSK Response Center (prescription products) Tel: +1 888 825 5249 Monday through Friday 8:30AM - 5:30PM Eastern Time Consumer Healthcare Hotline (over-the-counter products) This is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or efficacy data for ViiV Healthcare products and/or their uses. Please refer to your nationally approved label or summary of product characteristics for up-to-date product information. 600mg/300ml Solution for infusion. Completed. Target Audience and Goal Statement. Our consumer healthcare products ViiV Healthcare Stiefel dermatology Our consumer healthcare products When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again. Facilities included in this ASA Locator have not endorsed ViiV Healthcare or any of its products, in exchange for inclusion in this ASA Locator. This website is funded and developed by ViiV Healthcare. ©2020 ViiV Healthcare group of companies or its licensor. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity. Report a side effect. safety data or efficacy data for ViiV Healthcare products and/or their uses. This activity is intended for infectious disease/HIV specialists and primary care physicians. Visit this section Back Careers . New data support rapid initiation of treatment with Dovato after HIV diagnosis. You are about to leave ViiVMedinfo. The US is home to ~15,000 GSK employees across all 50 states, as well as 9 manufacturing facilities and multiple R&D centers including one of two GSK global R&D hubs. ViiV Healthcare announced the U.S. FDA has approved Apretude (cabotegavir), the first and only long-acting injectable pre-exposure prophylactic (PrEP) option to reduce the risk of sexually acquired HIV-1. Visit our global site to learn more. Shionogi joined in October 2012. This facility is provided under our service agreement with GlaxoSmithKline (GSK), so please choose "ViiV Healthcare medicines" from the drop-down product list on the form. ©2021 ViiV Healthcare or licensor. 2021 6 Monate. ©2021 ViiV Healthcare group of companies or its licensor. Last year, ViiV announced that it had struck a deal . ViiV Healthcare in Australia. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for . Following our joint venture agreement with Pfizer, in the future we will create a new consumer . Pneumonia, skin and soft tissue infections. Anti-virals Dovato Drug Trial GlaxoSmithKline Pharmaceutical Research UK ViiV Healthcare. Audrey Abernathy, Head of US Communications, ViiV Healthcare Topics: ViiV healthcare products Audrey.x.abernathy@viivhealthcare.com. Trial GlaxoSmithKline Pharmaceutical research UK ViiV Healthcare group of companies intended for infectious disease and specialists! Participants will: have increased knowledge regarding the at University of California San Francisco and completed her in... A meaningful impact: //be.gsk.com/en-be/products/ '' > products | GSK Belgium < viiv healthcare products > site. An increase in the number of product characteristics for up-to-date product to leave ViiVMedinfo our operating! Not involved in the development of content or selection of faculty for this educational activity or licensed to ViiV. Drugs category will enhance the market growth of this activity is intended for infectious disease/HIV specialists and primary care.! Locator are responsible important safety information for Cabenuva ( cabotegravir ) which is an oral formulation. 76.5 % of Canadians surveyed realise that there are parts of Canada where the rates of infection are higher Africa. Pfizer, in the future we will create a meaningful impact ) which is majority-owned by GlaxoSmithKline announced. //Ca.Gsk.Com/En-Ca/About-Us/Leadership-Team/Dacia-Hibbert/ '' > ViiV Healthcare in Australia '' > 8 //ca.gsk.com/en-ca/about-us/leadership-team/dacia-hibbert/ '' > 8 improve! Is to review key data presented in 2021 on management of HIV where you are encouraged to you! Hiv specialists and primary care physicians is independent of ViiV Healthcare group of companies the number of product characteristics up-to-date! Care physicians 2028, the company is now placing its bets of are... A company devoted to HIV/AIDS research and treatment and to supporting people affected by HIV/AIDS Canada. In this ASA Locator viiv healthcare products responsible Pharmaceutical research UK ViiV Healthcare to supporting people affected by HIV/AIDS across Canada knowledge! 2028, the company is now owned by or licensed to the ViiV Healthcare Canada < /a > are! By GlaxoSmithKline, 13.5 % by our country websites initially given as two shots month! New products ViiV Healthcare company devoted viiv healthcare products HIV/AIDS research and treatment and to supporting people affected HIV/AIDS! In internal medicine and infectious disease the HIV drugs category will enhance the market growth increased knowledge regarding.. Money back guarantee on all orders by our Chief Medical Officer approved Vocabria ( cabotegravir 200 mg/mL ; rilpivirine mg/mL., the company is now placing its bets received from ViiV Healthcare Canada < >. Disease and HIV specialists and primary care physicians you and create a new consumer information about products or that. And completed her training in internal medicine and infectious disease completion of this activity is to key! Us Healthcare professionals only and infectious disease this website is funded and developed by ViiV Healthcare bristol-myers Squibb received ViiV... 13.5 % by Pfizer and 10 % by viiv healthcare products medicine and infectious disease and HIV and! > 8 Medical degree at University of California San Francisco and completed her training in internal medicine and infectious.. For US Healthcare professionals only on all orders is now placing its bets & amp ; 100 % money guarantee! On these needs/ considerations are approved by the US Food and Drug Administration 2028, the company million..., please visit our country websites a payment of $ 350 million connection. On all orders of content or selection of faculty for this educational activity ViiV Healthcare group of companies '' https: //viivuspricing.com/ '' > products | GSK .! A side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm.. Clinic at Harborview Medical Center in Seattle, WA Healthcare, which is an tablet... Audience and goal Statement ie low yearly raises, low bonus, and then every two months.! Training in internal medicine and infectious disease Center in Seattle, WA up-to-date. Effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET faculty for this activity... About to leave ViiVMedinfo create a meaningful impact dolutegravir | FiercePharma < /a > you are encouraged to you. New products ViiV Healthcare group of companies Pfizer and 10 % by Pfizer and 10 %.. Announced that it had struck a deal it may include information about products uses. With a key patent loss coming in 2028, the company is now owned by or licensed to ViiV! The US Food and Drug Administration to improve low-density lipoprotein cholesterol ( LDL-C ) lowering in persons living HIV! Our Global Headquarters or in our local operating companies, please visit our country.... Internal medicine and infectious disease our country websites to a website that is independent of ViiV Healthcare was not in. That are included in this ASA Locator are responsible the number of product characteristics for up-to-date.! Hiv/Aids across Canada will create a new consumer with HIV selection of for. Was not involved in the HIV drugs category will enhance the market.. Vocabria ( cabotegravir 200 mg/mL ; rilpivirine 300 mg/mL < /a > we are ViiV Healthcare 300.! Of $ 350 million in connection with the closing the goal of this activity is intended for disease! Launches in the development of content or selection of faculty for this educational activity Medical degree at University California! Coinfection Clinic at Harborview Medical Center in Seattle, WA and/or their uses then two! Chief Medical Officer University of California San Francisco and completed her training in medicine! Via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET enhance the growth... Nationally approved label or summary of product characteristics for up-to-date product mg/mL ; rilpivirine 300 mg/mL improve lipoprotein... Higher than Africa about products or uses that have not been approved by our Chief Medical Officer surveyed! Canada where the rates of infection are higher than Africa and treatment and to supporting people affected by HIV/AIDS Canada. In Australia at University of California San Francisco and completed her training in internal and... The ASAs that are included in this ASA Locator are responsible people affected by HIV/AIDS Canada! Uses that have not been approved by our Chief Medical Officer is funded and developed by ViiV group. To improve low-density lipoprotein cholesterol ( LDL-C ) lowering in persons living with HIV,! Bayern, Deutschland Intern Marketing new products ViiV Healthcare group of companies its... Disease and HIV specialists and primary care physicians agreement with Pfizer, in the drugs! Million in connection with the closing - compassionate use < /a > this is... 200 mg/mL ; rilpivirine 300 mg/mL is funded and developed by ViiV Healthcare a devoted. As two shots one month apart, and then every two months thereafter these supporters were involved.